Trade Applied Therapeutics Inc - APLT CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.0360 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.024901% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.002679% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 7.687 |
| Open | 7.717 |
| 1-Year Change | 251.4% |
| Day's Range | 7.567 - 8.017 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Oct 4, 2024 | 7.6870 | -0.2300 | -2.91% | 7.9170 | 8.0070 | 7.5570 |
| Oct 3, 2024 | 7.8470 | -0.4500 | -5.42% | 8.2970 | 8.3270 | 7.6370 |
| Oct 2, 2024 | 8.3770 | 0.1100 | 1.33% | 8.2670 | 8.5670 | 8.1470 |
| Oct 1, 2024 | 8.3770 | 0.0100 | 0.12% | 8.3670 | 8.6170 | 8.0670 |
| Sep 30, 2024 | 8.4970 | 0.2800 | 3.41% | 8.2170 | 8.8470 | 8.1370 |
| Sep 27, 2024 | 8.2570 | -0.1600 | -1.90% | 8.4170 | 8.5970 | 8.1370 |
| Sep 26, 2024 | 8.3970 | -0.0700 | -0.83% | 8.4670 | 8.7670 | 8.1970 |
| Sep 25, 2024 | 8.3570 | 0.3600 | 4.50% | 7.9970 | 8.5770 | 7.9970 |
| Sep 24, 2024 | 8.0870 | 0.4800 | 6.31% | 7.6070 | 8.2270 | 7.4870 |
| Sep 23, 2024 | 7.6670 | -0.0200 | -0.26% | 7.6870 | 8.0870 | 7.5870 |
| Sep 20, 2024 | 7.6970 | -0.2000 | -2.53% | 7.8970 | 8.3270 | 7.5170 |
| Sep 19, 2024 | 7.9770 | -0.0100 | -0.13% | 7.9870 | 8.8370 | 7.8170 |
| Sep 18, 2024 | 7.8370 | 1.3200 | 20.25% | 6.5170 | 8.3770 | 6.4470 |
| Sep 17, 2024 | 4.6370 | -0.0100 | -0.22% | 4.6470 | 4.7670 | 4.6070 |
| Sep 16, 2024 | 4.6770 | -0.2100 | -4.30% | 4.8870 | 4.9670 | 4.5370 |
| Sep 13, 2024 | 4.8770 | -0.0100 | -0.20% | 4.8870 | 4.9270 | 4.5970 |
| Sep 12, 2024 | 4.8670 | -0.2600 | -5.07% | 5.1270 | 5.3670 | 4.8370 |
| Sep 11, 2024 | 5.1870 | 0.0500 | 0.97% | 5.1370 | 5.3570 | 4.9870 |
| Sep 10, 2024 | 5.1784 | -0.4800 | -8.48% | 5.6584 | 5.7284 | 5.1284 |
| Sep 9, 2024 | 5.7484 | 0.0600 | 1.05% | 5.6884 | 5.9784 | 5.6884 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Applied Therapeutics, Inc. Company profile
About Applied Therapeutics Inc
Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing a pipeline of product candidates against validated molecular targets in indications of high unmet medical need. The Company’s molecular target is aldose reductase (AR), an enzyme that converts glucose to sorbitol under oxidative stress conditions. Its product candidates include AT-007, AT-001, AT-003 and AT-104. The Company’s AT-007 is a central nervous system (CNS) penetrant ARI, which is developed for the treatment of galactosemia. AT-001 is an aldose reductase inhibitor (ARI) with exposure and nerve permeability. AT-001 is developed for the treatment of diabetic cardiomyopathy (DbCM), fatal fibrosis of the heart. Its AT-003 is an ARI designed to cross through the back of the eye when dosed orally. AT-003 is developed for the treatment of diabetic retinopathy (DR). AT-104 is a dual selective PI3K inhibitor in preclinical development for T Cell Acute Lymphoblastic Leukemia (T-ALL).
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Applied Therapeutics Inc revenues was not reported. Net loss increased 12% to $105.6M. Higher net loss reflects General and administrative - Balancing increase of 66% to $15.7M (expense), Stock-based Compensation in SGA increase of 55% to $8.4M (expense), Other general & administrative expenses increase of 73% to $5.4M (expense).
| Industry: | Bio Therapeutic Drugs |
545 5Th Avenue, Suite 1400
NEW YORK
NEW YORK 10017
US
News
Gold's recent Story
Last week, we explored the key price drivers of gold, and how they impacted the price of the precious metal this year and last. Now, we’ll bring these factors to life in a chart, showing you ten instances the gold price responded to critical fundamental events, including central bank policies, global economic data, and geopolitical events.
15:36, 7 October 2024
September US Non-Farm Payrolls Preview
Kyle Rodda, Senior Market Analyst at Capital.com, previews the US Non-Farm Payrolls report for September. The article discusses market expectations of a stable labor market with 150,000 new jobs, an unchanged unemployment rate of 4.2%, and steady annual wage growth at 3.8%. It also highlights potential rate cuts by the Federal Reserve, revisions to past payroll data, and the reaction of various markets such as the US Dollar, S&P 500, and gold.
07:59, 2 October 2024
Market of the Month - Gold, an overview
In 2024, gold has been on an upward trajectory, hitting high after high as global markets face ongoing challenges. This precious metal, long seen as a safe haven, has been proving its worth, drawing attention from traders around the world as its bullish surge continues.
06:00, 30 September 2024
RBA Preview: Rates to remain unchanged with inflation-fighting still the focus
RBA Governor Michelle Bullock emphasizes inflation challenges for Australia's economy, citing supply shocks and demand-supply imbalances. Discover insights on CPI trends, interest rates, and the central bank's strategy for managing price pressures in 2024.
12:27, 20 September 2024
BoE Preview: no change expected but forward guidance will be key
The BoE is forecasted to leave rates unchanged in September as UK CPI remains stubborn.
14:53, 19 September 2024
FOMC Decision Review: A 50 point cut but the markets responded in a mixed fashion
Discover the US Federal Reserve’s latest 50 basis point cut and how the markets reacted. Stocks surged, the US Dollar fell, and the Fed hints at more aggressive cuts ahead.
11:30, 19 September 2024
Bank of Japan Preview
The Bank of Japan will meet on September 20, 2024, with markets anticipating minimal policy changes. However, inflation risks remain, with core CPI at 2.7% and potential for future interest rate hikes.
09:40, 17 September 2024People also watch
Still looking for a broker you can trust?
Join the 650,000+ traders worldwide that chose to trade with Capital.com